Report Detail

Request for Sample of this report

Chemical & Material Global Sofosbuvir (CAS 1190307-88-0) Sales Market Report 2021

  • RnM3422441
    • |
  • 15 June, 2021
    • |
  • Global
    • |
  • 137 Pages
    • |
  • QYResearch
    • |
  • Chemical & Material

The report is about Sofosbuvir API market.

Market Analysis and Insights: Global Sofosbuvir (CAS 1190307-88-0) Market
The global Sofosbuvir (CAS 1190307-88-0) market was valued at US$ XX in 2020 and will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2022-2027.

Global Sofosbuvir (CAS 1190307-88-0) Scope and Market Size
The global Sofosbuvir (CAS 1190307-88-0) market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Sofosbuvir (CAS 1190307-88-0) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.

Segment by Type
Purity ≥ 98%
Purity ＜ 98%

Segment by Application
Adults Patients
Elderly Patients

The Sofosbuvir (CAS 1190307-88-0) market is analysed and market size information is provided by regions (countries). Segment by Application, the Sofosbuvir (CAS 1190307-88-0) market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.

By Company
Teva Pharmaceutical Industries Ltd
DONG BANG FUTURE TECH & LIFE CO., LTD
Beaukev Pharma International Pvt.Ltd
DEAFARMA
Tecoland
Anhui HaiKang Pharmaceutical Co. Ltd
Shanghai Haoyuan Chemexpress Co., Ltd
Beijing Kawin Technology Share-holding Co
Hangzhou Longshine Bio-Tech Co


1 Sofosbuvir (CAS 1190307-88-0) Market Overview

  • 1.1 Sofosbuvir (CAS 1190307-88-0) Product Scope
  • 1.2 Sofosbuvir (CAS 1190307-88-0) Segment by Type
    • 1.2.1 Global Sofosbuvir (CAS 1190307-88-0) Sales by Type (2016 & 2021 & 2027)
    • 1.2.2 Purity ≥ 98%
    • 1.2.3 Purity ＜ 98%
  • 1.3 Sofosbuvir (CAS 1190307-88-0) Segment by Application
    • 1.3.1 Global Sofosbuvir (CAS 1190307-88-0) Sales Comparison by Application (2016 & 2021 & 2027)
    • 1.3.2 Adults Patients
    • 1.3.3 Elderly Patients
  • 1.4 Sofosbuvir (CAS 1190307-88-0) Market Estimates and Forecasts (2016-2027)
    • 1.4.1 Global Sofosbuvir (CAS 1190307-88-0) Market Size in Value Growth Rate (2016-2027)
    • 1.4.2 Global Sofosbuvir (CAS 1190307-88-0) Market Size in Volume Growth Rate (2016-2027)
    • 1.4.3 Global Sofosbuvir (CAS 1190307-88-0) Price Trends (2016-2027)

2 Sofosbuvir (CAS 1190307-88-0) Estimates and Forecasts by Region

  • 2.1 Global Sofosbuvir (CAS 1190307-88-0) Market Size by Region: 2016 VS 2021 VS 2027
  • 2.2 Global Sofosbuvir (CAS 1190307-88-0) Retrospective Market Scenario by Region (2016-2021)
    • 2.2.1 Global Sofosbuvir (CAS 1190307-88-0) Sales Market Share by Region (2016-2021)
    • 2.2.2 Global Sofosbuvir (CAS 1190307-88-0) Revenue Market Share by Region (2016-2021)
  • 2.3 Global Sofosbuvir (CAS 1190307-88-0) Market Estimates and Forecasts by Region (2022-2027)
    • 2.3.1 Global Sofosbuvir (CAS 1190307-88-0) Sales Estimates and Forecasts by Region (2022-2027)
    • 2.3.2 Global Sofosbuvir (CAS 1190307-88-0) Revenue Forecast by Region (2022-2027)
  • 2.4 Geographic Market Analysis: Market Facts & Figures
    • 2.4.1 North America Sofosbuvir (CAS 1190307-88-0) Estimates and Projections (2016-2027)
    • 2.4.2 Europe Sofosbuvir (CAS 1190307-88-0) Estimates and Projections (2016-2027)
    • 2.4.3 China Sofosbuvir (CAS 1190307-88-0) Estimates and Projections (2016-2027)
    • 2.4.4 Japan Sofosbuvir (CAS 1190307-88-0) Estimates and Projections (2016-2027)
    • 2.4.5 Southeast Asia Sofosbuvir (CAS 1190307-88-0) Estimates and Projections (2016-2027)
    • 2.4.6 India Sofosbuvir (CAS 1190307-88-0) Estimates and Projections (2016-2027)

3 Global Sofosbuvir (CAS 1190307-88-0) Competition Landscape by Players

  • 3.1 Global Top Sofosbuvir (CAS 1190307-88-0) Players by Sales (2016-2021)
  • 3.2 Global Top Sofosbuvir (CAS 1190307-88-0) Players by Revenue (2016-2021)
  • 3.3 Global Sofosbuvir (CAS 1190307-88-0) Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Sofosbuvir (CAS 1190307-88-0) as of 2020)
  • 3.4 Global Sofosbuvir (CAS 1190307-88-0) Average Price by Company (2016-2021)
  • 3.5 Manufacturers Sofosbuvir (CAS 1190307-88-0) Manufacturing Sites, Area Served, Product Type
  • 3.6 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Global Sofosbuvir (CAS 1190307-88-0) Market Size by Type

  • 4.1 Global Sofosbuvir (CAS 1190307-88-0) Historic Market Review by Type (2016-2021)
    • 4.1.1 Global Sofosbuvir (CAS 1190307-88-0) Sales Market Share by Type (2016-2021)
    • 4.1.2 Global Sofosbuvir (CAS 1190307-88-0) Revenue Market Share by Type (2016-2021)
    • 4.1.3 Global Sofosbuvir (CAS 1190307-88-0) Price by Type (2016-2021)
  • 4.2 Global Sofosbuvir (CAS 1190307-88-0) Market Estimates and Forecasts by Type (2022-2027)
    • 4.2.1 Global Sofosbuvir (CAS 1190307-88-0) Sales Forecast by Type (2022-2027)
    • 4.2.2 Global Sofosbuvir (CAS 1190307-88-0) Revenue Forecast by Type (2022-2027)
    • 4.2.3 Global Sofosbuvir (CAS 1190307-88-0) Price Forecast by Type (2022-2027)

5 Global Sofosbuvir (CAS 1190307-88-0) Market Size by Application

  • 5.1 Global Sofosbuvir (CAS 1190307-88-0) Historic Market Review by Application (2016-2021)
    • 5.1.1 Global Sofosbuvir (CAS 1190307-88-0) Sales Market Share by Application (2016-2021)
    • 5.1.2 Global Sofosbuvir (CAS 1190307-88-0) Revenue Market Share by Application (2016-2021)
    • 5.1.3 Global Sofosbuvir (CAS 1190307-88-0) Price by Application (2016-2021)
  • 5.2 Global Sofosbuvir (CAS 1190307-88-0) Market Estimates and Forecasts by Application (2022-2027)
    • 5.2.1 Global Sofosbuvir (CAS 1190307-88-0) Sales Forecast by Application (2022-2027)
    • 5.2.2 Global Sofosbuvir (CAS 1190307-88-0) Revenue Forecast by Application (2022-2027)
    • 5.2.3 Global Sofosbuvir (CAS 1190307-88-0) Price Forecast by Application (2022-2027)

6 North America Sofosbuvir (CAS 1190307-88-0) Market Facts & Figures

  • 6.1 North America Sofosbuvir (CAS 1190307-88-0) Sales by Company
    • 6.1.1 North America Sofosbuvir (CAS 1190307-88-0) Sales by Company (2016-2021)
    • 6.1.2 North America Sofosbuvir (CAS 1190307-88-0) Revenue by Company (2016-2021)
  • 6.2 North America Sofosbuvir (CAS 1190307-88-0) Sales Breakdown by Type
    • 6.2.1 North America Sofosbuvir (CAS 1190307-88-0) Sales Breakdown by Type (2016-2021)
    • 6.2.2 North America Sofosbuvir (CAS 1190307-88-0) Sales Breakdown by Type (2022-2027)
  • 6.3 North America Sofosbuvir (CAS 1190307-88-0) Sales Breakdown by Application
    • 6.3.1 North America Sofosbuvir (CAS 1190307-88-0) Sales Breakdown by Application (2016-2021)
    • 6.3.2 North America Sofosbuvir (CAS 1190307-88-0) Sales Breakdown by Application (2022-2027)

7 Europe Sofosbuvir (CAS 1190307-88-0) Market Facts & Figures

  • 7.1 Europe Sofosbuvir (CAS 1190307-88-0) Sales by Company
    • 7.1.1 Europe Sofosbuvir (CAS 1190307-88-0) Sales by Company (2016-2021)
    • 7.1.2 Europe Sofosbuvir (CAS 1190307-88-0) Revenue by Company (2016-2021)
  • 7.2 Europe Sofosbuvir (CAS 1190307-88-0) Sales Breakdown by Type
    • 7.2.1 Europe Sofosbuvir (CAS 1190307-88-0) Sales Breakdown by Type (2016-2021)
    • 7.2.2 Europe Sofosbuvir (CAS 1190307-88-0) Sales Breakdown by Type (2022-2027)
  • 7.3 Europe Sofosbuvir (CAS 1190307-88-0) Sales Breakdown by Application
    • 7.3.1 Europe 137 Sales Breakdown by Application (2016-2021)
    • 7.3.2 Europe 137 Sales Breakdown by Application (2022-2027)

8 China Sofosbuvir (CAS 1190307-88-0) Market Facts & Figures

  • 8.1 China Sofosbuvir (CAS 1190307-88-0) Sales by Company
    • 8.1.1 China Sofosbuvir (CAS 1190307-88-0) Sales by Company (2016-2021)
    • 8.1.2 China Sofosbuvir (CAS 1190307-88-0) Revenue by Company (2016-2021)
  • 8.2 China Sofosbuvir (CAS 1190307-88-0) Sales Breakdown by Type
    • 8.2.1 China Sofosbuvir (CAS 1190307-88-0) Sales Breakdown by Type (2016-2021)
    • 8.2.2 China Sofosbuvir (CAS 1190307-88-0) Sales Breakdown by Type (2022-2027)
  • 8.3 China Sofosbuvir (CAS 1190307-88-0) Sales Breakdown by Application
    • 8.3.1 China 247 Sales Breakdown by Application (2016-2021)
    • 8.3.2 China 247 Sales Breakdown by Application (2022-2027)

9 Japan Sofosbuvir (CAS 1190307-88-0) Market Facts & Figures

  • 9.1 Japan Sofosbuvir (CAS 1190307-88-0) Sales by Company
    • 9.1.1 Japan Sofosbuvir (CAS 1190307-88-0) Sales by Company (2016-2021)
    • 9.1.2 Japan Sofosbuvir (CAS 1190307-88-0) Revenue by Company (2016-2021)
  • 9.2 Japan Sofosbuvir (CAS 1190307-88-0) Sales Breakdown by Type
    • 9.2.1 Japan Sofosbuvir (CAS 1190307-88-0) Sales Breakdown by Type (2016-2021)
    • 9.2.2 Japan Sofosbuvir (CAS 1190307-88-0) Sales Breakdown by Type (2022-2027)
  • 9.3 Japan Sofosbuvir (CAS 1190307-88-0) Sales Breakdown by Application
    • 9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)
    • 9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)

10 Southeast Asia Sofosbuvir (CAS 1190307-88-0) Market Facts & Figures

  • 10.1 Southeast Asia Sofosbuvir (CAS 1190307-88-0) Sales by Company
    • 10.1.1 Southeast Asia Sofosbuvir (CAS 1190307-88-0) Sales by Company (2016-2021)
    • 10.1.2 Southeast Asia Sofosbuvir (CAS 1190307-88-0) Revenue by Company (2016-2021)
  • 10.2 Southeast Asia Sofosbuvir (CAS 1190307-88-0) Sales Breakdown by Type
    • 10.2.1 Southeast Asia Sofosbuvir (CAS 1190307-88-0) Sales Breakdown by Type (2016-2021)
    • 10.2.2 Southeast Asia Sofosbuvir (CAS 1190307-88-0) Sales Breakdown by Type (2022-2027)
  • 10.3 Southeast Asia Sofosbuvir (CAS 1190307-88-0) Sales Breakdown by Application
    • 10.3.1 Southeast Asia MT Sales Breakdown by Application (2016-2021)
    • 10.3.2 Southeast Asia MT Sales Breakdown by Application (2022-2027)

11 India Sofosbuvir (CAS 1190307-88-0) Market Facts & Figures

  • 11.1 India Sofosbuvir (CAS 1190307-88-0) Sales by Company
    • 11.1.1 India Sofosbuvir (CAS 1190307-88-0) Sales by Company (2016-2021)
    • 11.1.2 India Sofosbuvir (CAS 1190307-88-0) Revenue by Company (2016-2021)
  • 11.2 India Sofosbuvir (CAS 1190307-88-0) Sales Breakdown by Type
    • 11.2.1 India Sofosbuvir (CAS 1190307-88-0) Sales Breakdown by Type (2016-2021)
    • 11.2.2 India Sofosbuvir (CAS 1190307-88-0) Sales Breakdown by Type (2022-2027)
  • 11.3 India Sofosbuvir (CAS 1190307-88-0) Sales Breakdown by Application
    • 11.3.1 India Sofosbuvir (CAS 1190307-88-0) Sales Breakdown by Application (2016-2021)
    • 11.3.2 India Sofosbuvir (CAS 1190307-88-0) Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in Sofosbuvir (CAS 1190307-88-0) Business

  • 12.1 Teva Pharmaceutical Industries Ltd
    • 12.1.1 Teva Pharmaceutical Industries Ltd Corporation Information
    • 12.1.2 Teva Pharmaceutical Industries Ltd Business Overview
    • 12.1.3 Teva Pharmaceutical Industries Ltd Sofosbuvir (CAS 1190307-88-0) Sales, Revenue and Gross Margin (2016-2021)
    • 12.1.4 Teva Pharmaceutical Industries Ltd Sofosbuvir (CAS 1190307-88-0) Products Offered
    • 12.1.5 Teva Pharmaceutical Industries Ltd Recent Development
  • 12.2 DONG BANG FUTURE TECH & LIFE CO., LTD
    • 12.2.1 DONG BANG FUTURE TECH & LIFE CO., LTD Corporation Information
    • 12.2.2 DONG BANG FUTURE TECH & LIFE CO., LTD Business Overview
    • 12.2.3 DONG BANG FUTURE TECH & LIFE CO., LTD Sofosbuvir (CAS 1190307-88-0) Sales, Revenue and Gross Margin (2016-2021)
    • 12.2.4 DONG BANG FUTURE TECH & LIFE CO., LTD Sofosbuvir (CAS 1190307-88-0) Products Offered
    • 12.2.5 DONG BANG FUTURE TECH & LIFE CO., LTD Recent Development
  • 12.3 Beaukev Pharma International Pvt.Ltd
    • 12.3.1 Beaukev Pharma International Pvt.Ltd Corporation Information
    • 12.3.2 Beaukev Pharma International Pvt.Ltd Business Overview
    • 12.3.3 Beaukev Pharma International Pvt.Ltd Sofosbuvir (CAS 1190307-88-0) Sales, Revenue and Gross Margin (2016-2021)
    • 12.3.4 Beaukev Pharma International Pvt.Ltd Sofosbuvir (CAS 1190307-88-0) Products Offered
    • 12.3.5 Beaukev Pharma International Pvt.Ltd Recent Development
  • 12.4 DEAFARMA
    • 12.4.1 DEAFARMA Corporation Information
    • 12.4.2 DEAFARMA Business Overview
    • 12.4.3 DEAFARMA Sofosbuvir (CAS 1190307-88-0) Sales, Revenue and Gross Margin (2016-2021)
    • 12.4.4 DEAFARMA Sofosbuvir (CAS 1190307-88-0) Products Offered
    • 12.4.5 DEAFARMA Recent Development
  • 12.5 Tecoland
    • 12.5.1 Tecoland Corporation Information
    • 12.5.2 Tecoland Business Overview
    • 12.5.3 Tecoland Sofosbuvir (CAS 1190307-88-0) Sales, Revenue and Gross Margin (2016-2021)
    • 12.5.4 Tecoland Sofosbuvir (CAS 1190307-88-0) Products Offered
    • 12.5.5 Tecoland Recent Development
  • 12.6 Anhui HaiKang Pharmaceutical Co. Ltd
    • 12.6.1 Anhui HaiKang Pharmaceutical Co. Ltd Corporation Information
    • 12.6.2 Anhui HaiKang Pharmaceutical Co. Ltd Business Overview
    • 12.6.3 Anhui HaiKang Pharmaceutical Co. Ltd Sofosbuvir (CAS 1190307-88-0) Sales, Revenue and Gross Margin (2016-2021)
    • 12.6.4 Anhui HaiKang Pharmaceutical Co. Ltd Sofosbuvir (CAS 1190307-88-0) Products Offered
    • 12.6.5 Anhui HaiKang Pharmaceutical Co. Ltd Recent Development
  • 12.7 Shanghai Haoyuan Chemexpress Co., Ltd
    • 12.7.1 Shanghai Haoyuan Chemexpress Co., Ltd Corporation Information
    • 12.7.2 Shanghai Haoyuan Chemexpress Co., Ltd Business Overview
    • 12.7.3 Shanghai Haoyuan Chemexpress Co., Ltd Sofosbuvir (CAS 1190307-88-0) Sales, Revenue and Gross Margin (2016-2021)
    • 12.7.4 Shanghai Haoyuan Chemexpress Co., Ltd Sofosbuvir (CAS 1190307-88-0) Products Offered
    • 12.7.5 Shanghai Haoyuan Chemexpress Co., Ltd Recent Development
  • 12.8 Beijing Kawin Technology Share-holding Co
    • 12.8.1 Beijing Kawin Technology Share-holding Co Corporation Information
    • 12.8.2 Beijing Kawin Technology Share-holding Co Business Overview
    • 12.8.3 Beijing Kawin Technology Share-holding Co Sofosbuvir (CAS 1190307-88-0) Sales, Revenue and Gross Margin (2016-2021)
    • 12.8.4 Beijing Kawin Technology Share-holding Co Sofosbuvir (CAS 1190307-88-0) Products Offered
    • 12.8.5 Beijing Kawin Technology Share-holding Co Recent Development
  • 12.9 Hangzhou Longshine Bio-Tech Co
    • 12.9.1 Hangzhou Longshine Bio-Tech Co Corporation Information
    • 12.9.2 Hangzhou Longshine Bio-Tech Co Business Overview
    • 12.9.3 Hangzhou Longshine Bio-Tech Co Sofosbuvir (CAS 1190307-88-0) Sales, Revenue and Gross Margin (2016-2021)
    • 12.9.4 Hangzhou Longshine Bio-Tech Co Sofosbuvir (CAS 1190307-88-0) Products Offered
    • 12.9.5 Hangzhou Longshine Bio-Tech Co Recent Development

13 Sofosbuvir (CAS 1190307-88-0) Manufacturing Cost Analysis

  • 13.1 Sofosbuvir (CAS 1190307-88-0) Key Raw Materials Analysis
    • 13.1.1 Key Raw Materials
    • 13.1.2 Key Raw Materials Price Trend
    • 13.1.3 Key Suppliers of Raw Materials
  • 13.2 Proportion of Manufacturing Cost Structure
  • 13.3 Manufacturing Process Analysis of Sofosbuvir (CAS 1190307-88-0)
  • 13.4 Sofosbuvir (CAS 1190307-88-0) Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers

  • 14.1 Marketing Channel
  • 14.2 Sofosbuvir (CAS 1190307-88-0) Distributors List
  • 14.3 Sofosbuvir (CAS 1190307-88-0) Customers

15 Market Dynamics

  • 15.1 Sofosbuvir (CAS 1190307-88-0) Market Trends
  • 15.2 Sofosbuvir (CAS 1190307-88-0) Drivers
  • 15.3 Sofosbuvir (CAS 1190307-88-0) Market Challenges
  • 15.4 Sofosbuvir (CAS 1190307-88-0) Market Restraints

16 Research Findings and Conclusion

    17 Appendix

    • 17.1 Research Methodology
      • 17.1.1 Methodology/Research Approach
      • 17.1.2 Data Source
    • 17.2 Author List

    Summary:
    Get latest Market Research Reports on Sofosbuvir (CAS 1190307-88-0) . Industry analysis & Market Report on Sofosbuvir (CAS 1190307-88-0) is a syndicated market report, published as Global Sofosbuvir (CAS 1190307-88-0) Sales Market Report 2021. It is complete Research Study and Industry Analysis of Sofosbuvir (CAS 1190307-88-0) market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$4,000.00
    		$6,000.00
    		$8,000.00
    		3,092.00
    		4,638.00
    		6,184.00
    		3,724.00
    		5,586.00
    		7,448.00
    		610,760.00
    		916,140.00
    		1,221,520.00
    		337,600.00
    		506,400.00
    		675,200.00
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo